Literature DB >> 1812843

Day case ligation of patent ductus arteriosus in preterm infants: a 10 year review.

C R Satur1, D R Walker, D F Dickinson.   

Abstract

Since 1978, 136 preterm babies received ligation of a patent ductus arteriosus as day cases. A total of 122 babies whose notes were available for review, with a median gestational age of 27 weeks (range 23-35) and median birth weight of 960 g (range 470-2750), were transported distances of up to 80 miles. The median ages at ligation with and without previous medical management with indomethacin were 23 and 15 days, respectively. One hundred and ten (90%) babies were dependent on ventilatory support, but extubation was achieved at a median time of 10 days after ligation, regardless of postnatal age at the time of ligation. There were no deaths associated with the operation, and no complications resulting from transportation. The hospital mortality was 15 (12.3%), and the most important (and significant) adverse factor was a preoperative fractional inspiratory oxygen content greater than 0.3. The results of this study show that day case ligation of the patent ductus arteriosus is safe, and if it is carried out early will reduce the time before extubation and discharge from the intensive care unit.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1812843      PMCID: PMC1792999          DOI: 10.1136/adc.66.4.477

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  19 in total

1.  Patent ductus arteriosus in premature infants.

Authors:  M L POWELL
Journal:  Med J Aust       Date:  1963-07-13       Impact factor: 7.738

2.  The Killingbeck pediatric lung retractor.

Authors:  C M Satur; D R Walker
Journal:  Ann Thorac Surg       Date:  1990-03       Impact factor: 4.330

3.  Management of patent ductus arteriosus: a comparison of operative v pharmacologic treatment.

Authors:  S B Palder; M Z Schwartz; K R Tyson; C C Marr
Journal:  J Pediatr Surg       Date:  1987-12       Impact factor: 2.545

4.  Day-case ligation of patent ductus arteriosus in premature infants.

Authors:  P S Malone; K D Roberts; L D Abrams; S Jones; J Beasley
Journal:  J Pediatr Surg       Date:  1987-03       Impact factor: 2.545

5.  Operative closure of patent ductus arteriosus in premature infants in the neonatal intensive care unit.

Authors:  R L Taylor; F L Grover; P K Harman; M K Escobedo; R S Ramamurthy; J K Trinkle
Journal:  Am J Surg       Date:  1986-12       Impact factor: 2.565

6.  Patent ductus arteriosus in neonates with severe respiratory disease.

Authors:  G G Dudell; W M Gersony
Journal:  J Pediatr       Date:  1984-06       Impact factor: 4.406

7.  Recurrence of symptomatic patent ductus arteriosus in extremely premature infants, treated with indomethacin.

Authors:  M Mellander; B Leheup; D P Lindstrom; C Palme; T P Graham; M T Stahlman; R B Cotton
Journal:  J Pediatr       Date:  1984-07       Impact factor: 4.406

8.  Ligation of patent ductus arteriosus in very low birth weight infants.

Authors:  M G Nagle; M D Peyton; L H Harrison; R C Elkins
Journal:  Am J Surg       Date:  1981-12       Impact factor: 2.565

9.  Indomethacin treatment for patent ductus arteriosus in very low birthweight infants: double blind trial.

Authors:  P Rudd; P Montanez; K Hallidie-Smith; M Silverman
Journal:  Arch Dis Child       Date:  1983-04       Impact factor: 3.791

10.  Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study.

Authors:  W M Gersony; G J Peckham; R C Ellison; O S Miettinen; A S Nadas
Journal:  J Pediatr       Date:  1983-06       Impact factor: 4.406

View more
  11 in total

1.  Day case ligation of patent ductus arteriosus in premature infants.

Authors:  K L Dodd
Journal:  Arch Dis Child       Date:  1991-12       Impact factor: 3.791

2.  Patent ductus arteriosus in premature infants: A never-closing act.

Authors:  Bernard Thébaud; Thierry Lacaze-Mazmonteil
Journal:  Paediatr Child Health       Date:  2010-05       Impact factor: 2.253

Review 3.  Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants.

Authors:  Manoj N Malviya; Arne Ohlsson; Sachin S Shah
Journal:  Cochrane Database Syst Rev       Date:  2013-03-28

Review 4.  Patent ductus arteriosus in the newborn.

Authors:  N Archer
Journal:  Arch Dis Child       Date:  1993-11       Impact factor: 3.791

5.  Patent ductus arteriosus therapy: impact on neonatal and 18-month outcome.

Authors:  Juliette C Madan; Douglas Kendrick; James I Hagadorn; Ivan D Frantz
Journal:  Pediatrics       Date:  2009-02       Impact factor: 7.124

6.  Patent ductus arteriosus in premature neonates.

Authors:  Olachi J Mezu-Ndubuisi; Ghanshyam Agarwal; Aarti Raghavan; Jennifer T Pham; Kirsten H Ohler; Akhil Maheshwari
Journal:  Drugs       Date:  2012-05-07       Impact factor: 9.546

7.  Role of prophylactic surgical ligation of patent ductus arteriosus in extremely low birth weight infants: Systematic review and implications for clinical practice.

Authors:  Rafat Mosalli; Khalid Alfaleh; Bosco Paes
Journal:  Ann Pediatr Cardiol       Date:  2009-07

8.  Outcome following patent ductus arteriosus ligation in premature infants: a retrospective cohort analysis.

Authors:  Lleona C L Lee; Angela Tillett; Robert Tulloh; Robert Yates; Wilf Kelsall
Journal:  BMC Pediatr       Date:  2006-05-11       Impact factor: 2.125

9.  Outcome following surgical closure of patent ductus arteriosus in very low birth weight infants in neonatal intensive care unit.

Authors:  Ga Yeun Lee; Young Bae Sohn; Myo Jing Kim; Ga Won Jeon; Jae Won Shim; Yun Sil Chang; June Huh; I-Seok Kang; Ji-Hyuk Yang; Tae-Gook Jun; Pyo Won Park; Won Soon Park; Heung Jae Lee
Journal:  Yonsei Med J       Date:  2008-04-30       Impact factor: 2.759

Review 10.  Prophylactic surgical ligation of patent ductus arteriosus for prevention of mortality and morbidity in extremely low birth weight infants.

Authors:  R Mosalli; K Alfaleh
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.